Hsiao et al. provided detailed evidence that the analgesic effect of oral eicosapentaenoic acid (EPA) in fibromyalgia model mice was associated with suppressed astrocyte activation and the reduced release of proinflammatory signaling factors, including HMGB1 and S100B. The gene discussed is S100B; the disease is fibromyalgia.